简介：
Overview
This protocol describes a high throughput, real-time assay designed to identify eukaryotic cell-penetrant antimicrobials targeting intracellular bacterial pathogens while assessing eukaryotic cell cytotoxicity. The method allows for simultaneous detection of bacterial growth and mammalian cell toxicity using non-destructive techniques.
Key Study Components
Area of Science
- Microbiology
- Pharmacology
- Cell Biology
Background
- Intracellular bacterial infections pose significant challenges in treatment.
- Identifying non-toxic antimicrobials is crucial for effective therapy.
- Real-time assays provide a novel approach to antimicrobial discovery.
- Scalability is a key consideration when assaying large compound libraries.
Purpose of Study
- To develop a method for identifying small molecule inhibitors of intracellular bacterial growth.
- To ensure that identified compounds are non-toxic to host cells.
- To facilitate high-resolution dose-response studies.
Methods Used
- Real-time assays for simultaneous detection of bacterial growth and cell toxicity.
- Digital dispensing technology for high-throughput screening.
- Two- and three-dimensional synergy studies.
- Assessment of over ten thousand compounds in a single session.
Main Results
- Successful identification of eukaryotic cell-penetrant antimicrobials.
- Demonstrated non-toxicity of selected compounds to mammalian cells.
- Established a scalable method for high-throughput antimicrobial discovery.
- Enabled detailed dose-response and synergy analysis.
Conclusions
- The developed assay is a valuable tool in antimicrobial discovery.
- It allows for the identification of effective compounds with minimal host toxicity.
- This method can significantly advance research in combating intracellular bacterial infections.
What is the main advantage of this assay?
The main advantage is the simultaneous detection of bacterial growth and mammalian cell toxicity using non-destructive methods.
How scalable is this method?
The method is highly scalable, allowing for the assessment of over ten thousand compounds in a single session.
What types of compounds does this assay identify?
It identifies small molecule inhibitors that can penetrate intracellular compartments and kill pathogens without harming host cells.
What technologies are combined in this study?
The study combines real-time assays with digital dispensing technology for high-resolution studies.
What are the implications of this research?
This research can significantly advance the field of antimicrobial discovery and treatment of intracellular infections.
繁體中文
